Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

10401	Companies
217318	Keywords
146968	Articles
115052	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 04/24/2025 at 07:16, 1 year ago

Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx

HDP-101 Heidelberg Pharma AG TLX250-CDx ATAC Candidates HDP-102
BRIEF

published on 03/26/2025 at 09:28, 1 year 1 month ago

Heidelberg Pharma to Showcase ADC Innovations at AACR 2025

Heidelberg Pharma ADC Technology HDP-201 AACR 2025 NAMPT Inhibitors
BRIEF

published on 03/26/2025 at 09:28, 1 year 1 month ago

Heidelberg Pharma présentera ses innovations ADC à l'AACR 2025

Heidelberg Pharma HDP-201 Technologie ADC AACR 2025 Inhibiteurs De NAMPT
PRESS RELEASE

published on 03/26/2025 at 09:23, 1 year 1 month ago

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
Heidelberg Pharma AG to present latest ADC research results and advancements at AACR Annual Meeting 2025, showcasing Exatecan-based and Amanitin-based ADC technology platforms

Heidelberg Pharma ADC AACR Annual Meeting 2025 Exatecan-based ADC Amanitin-based ADC
BRIEF

published on 03/21/2025 at 07:12, 1 year 1 month ago

Heidelberg Pharma Reports 2024 Financial Results and Clinical Progress

Clinical Trials Heidelberg Pharma ADC Technology Multiple Myeloma 2024 Financial Results
BRIEF

published on 03/21/2025 at 07:12, 1 year 1 month ago

Heidelberg Pharma publie ses résultats financiers et ses progrès cliniques pour 2024

Essais Cliniques Heidelberg Pharma Myélome Multiple Résultats Financiers 2024 Technologie ADC
PRESS RELEASE

published on 03/21/2025 at 07:07, 1 year 1 month ago

Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Heidelberg Pharma AG reports successful business performance in 2024 with improved financial figures including clinical trial results for HDP-101 in multiple myeloma and upcoming study for HDP-102. Financial outlook and strategy for 2025 highlighted

Financial Results Clinical Trial Heidelberg Pharma AG 2025 Outlook ATAC Technology
BRIEF

published on 03/13/2025 at 07:35, 1 year 2 months ago

Heidelberg Pharma Adjusts Royalty Financing with HealthCare Royalty

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Financing TLX250-CDx
BRIEF

published on 03/13/2025 at 07:35, 1 year 2 months ago

Heidelberg Pharma ajuste son financement par redevances avec HealthCare Royalty

Heidelberg Pharma Financement Des Redevances Approbation De La FDA TLX250-CDx Redevance Des Soins De Santé
PRESS RELEASE

published on 03/13/2025 at 07:30, 1 year 2 months ago

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Heidelberg Pharma and HealthCare Royalty amend royalty financing agreement, providing for USD 20 million payment and extending cash runway into 2027

Amendment Heidelberg Pharma HealthCare Royalty Royalty Financing Cash Runway

Accesswire

Published on 05/13/2026 at 19:25, 2 hours 35 minutes ago

Bolt Metals Executes Option to Acquire The High-Grade Floralia Iron Project, Prepares for Maiden Drill Program at Northwind
Published on 05/13/2026 at 15:30, 6 hours 30 minutes ago

All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities
Published on 05/13/2026 at 15:05, 6 hours 55 minutes ago

Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Published on 05/13/2026 at 15:00, 7 hours ago

ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET
Published on 05/13/2026 at 15:00, 7 hours ago

Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program

View all ACCESSWIRE

EQS Group

Published on 05/13/2026 at 20:21, 1 hour 39 minutes ago

Northern Data provides operational update
Published on 05/13/2026 at 20:18, 1 hour 42 minutes ago

EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 19:28, 2 hours 31 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/13/2026 at 19:14, 2 hours 45 minutes ago

EQS-Adhoc: Oldenburgische Landesbank AG: Oldenburgische Landesbank AG intends to call its Additional Tier 1 bond
Published on 05/13/2026 at 18:15, 3 hours 45 minutes ago

Africa Energy Forum 2026: Building Africa's Industrialised Future

Les Echos

Published on 05/13/2026 at 18:02, 3 hours 58 minutes ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 4 hours ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 4 hours ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 4 hours ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 4 hours 15 minutes ago

Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.

View all LES ECHOS COMFI WIRE